{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:47:50Z","timestamp":1650862070623},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf01709664","type":"journal-article","created":{"date-parts":[[2005,6,11]],"date-time":"2005-06-11T21:15:10Z","timestamp":1118524510000},"page":"37-39","source":"Crossref","is-referenced-by-count":11,"title":["Chemotherapy with cytosine arabinoside in a child with Burkitt's lymphoma on maintenance hemodialysis and hemofiltration"],"prefix":"10.1007","volume":"67","author":[{"given":"J. M. B.","family":"P\u00f6schl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Mehls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01709664_CR1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0378-4347(00)81894-0","volume":"146","author":"J Boutagy","year":"1978","unstructured":"Boutagy J, Harvey DJ (1978) Determination of cytosine arabinoside in human plasma by gas chromatography with a nitrogen-sensitive detector and by gas chromatography-mass spectrometry. J Chromatography 146:283\u2013296","journal-title":"J Chromatography"},{"key":"BF01709664_CR2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-4347(00)80248-0","volume":"225","author":"H Breithaupt","year":"1981","unstructured":"Breithaupt H, Schick J (1981) Determination of cytosine and uracil arabinoside in human plasma and cerebrospinal fluid by high-performance liquid chromatography. J Chromatography 225:99\u2013106","journal-title":"J Chromatography"},{"key":"BF01709664_CR3","first-page":"13","volume":"216","author":"RL Capizzi","year":"1983","unstructured":"Capizzi RL, Yang JL, Cheng E (1983) Preclinical and clinical pharmacology of high-dose Ara-C: aspects of self potentiation accounting for its unique therapeutic utility. 13th Int. Congress of Chemotherapy. Proc 216:13\u201319","journal-title":"13th Int. Congress of Chemotherapy. Proc"},{"key":"BF01709664_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.1979.tb01005.x","volume":"8","author":"AL Harris","year":"1979","unstructured":"Harris AL, Potter C, Bunch C (1979) Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukemia. Br J Clin Pharmacol 8:219\u2013227","journal-title":"Br J Clin Pharmacol"},{"key":"BF01709664_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0378-4347(00)80110-3","volume":"223","author":"P Linssen","year":"1981","unstructured":"Linssen P, Dreuthe-Schenk A, Wessels H, Haanen C (1981) Determination of 1-\u03b2-D-arabinofuranosylcytosine and 1-\u03b2-Darabinofuranosyluracil in human plasma by high-performance liquid chromatography. J Chromatography 223:371\u2013378","journal-title":"J Chromatography"},{"key":"BF01709664_CR6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1200\/JCO.1984.2.10.1092","volume":"2","author":"J Ochs","year":"1984","unstructured":"Ochs J, Sinkule A, Danks M, et al. (1984) Continuous-Infusion high-dose cytosine arabinoside in refractory childhood leukemia. J Clin Oncol 2:1092\u20131097","journal-title":"J Clin Oncol"},{"key":"BF01709664_CR7","first-page":"1","volume":"12","author":"CM Riva","year":"1985","unstructured":"Riva CM (1985) Pharmacokinetics and cellular determinants of response to 1-\u03b2-arabinofuranosylcytosine (Ara-C). Semin Oncol [Suppl 3] 12:1\u20138","journal-title":"Semin Oncol [Suppl 3]"},{"key":"BF01709664_CR8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000215706","volume":"8","author":"S Seeber","year":"1985","unstructured":"Seeber S (1985) Grundlagen der hochdosierten Cytarabinosid-Behandlung. Onkologie 8:4\u20137","journal-title":"Onkologie"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01709664\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T08:47:35Z","timestamp":1557305255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01709664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF01709664"],"URL":"https:\/\/doi.org\/10.1007\/bf01709664","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}